Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene - Wikidata - wikimedia - TriplyDB

Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

http://www.wikidata.org/entity/Q28246156

about

Molecular chaperone properties of serum amyloid P component Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice Family Wide Molecular Adaptations to Underground Life in African Mole-Rats Revealed by Phylogenomic Analysis.Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component Pentraxins: structure, function, and role in inflammation Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae.The major acute-phase protein, serum amyloid P component, in mice is not involved in endogenous resistance against tumor necrosis factor alpha-induced lethal hepatitis, shock, and skin necrosis.Amyloidosis and the respiratory tract Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use.Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.Accumulation and expression of serum amyloid P component in human atherosclerotic lesions.The relation of proteoglycans, serum amyloid P and apo E to amyloidosis current status, 2000.Requirement for complement in antibody responses is not explained by the classic pathway activator IgM.Antibodies to human serum amyloid P component eliminate visceral amyloid deposits.Dynamic of beta(2)-microglobulin fibril formation and reabsorption: the role of proteolysis.Novel drugs targeting transthyretin amyloidosis.Renal amyloidosis as a late complication of Crohn's disease: a case report and review of the literature from Japan Inhibition of TTR aggregation-induced cell death--a new role for serum amyloid P component.The in vivo expression of actin/salt-resistant hyperactive DNase I inhibits the development of anti-ssDNA and anti-histone autoantibodies in a murine model of systemic lupus erythematosus Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-alpha- and beta-d-glucose: implications for the treatment of various amyloidoses.Persistent lung inflammation and fibrosis in serum amyloid P component (APCs-/-) knockout mice Brain serum amyloid P levels are reduced in individuals that lack dementia while having Alzheimer's disease neuropathology.Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen A protective role for innate immunity in systemic lupus erythematosus.Pattern recognition by pentraxins Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation.Drug Insight: emerging therapies for amyloidosis.Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo Amyloid persistence in decellularized liver: biochemical and histopathological characterization.CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium.Search for amyloid-binding proteins by affinity chromatography.An insight into the changes in human plasma proteome on adaptation to hypobaric hypoxia Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity.Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro.Regulation of B cell tolerance by 129-derived chromosome 1 loci in C57BL/6 mice.Pathogenetic mechanisms of amyloid A amyloidosis.Amyloid and inflammation.Amyloid fibrils: abnormal protein assembly.

P2860

Q22254102-7CE1B588-CA40-4F1C-B9C3-1D848C11C6EF Q24321663-A574FA5C-E66E-44AB-BB16-1F1989EEC208 Q24796292-6F7279FF-3CCD-4D00-AF07-78D7757FD461 Q24799092-625441EC-A71E-4649-8574-34226CFA87A5 Q27300147-A5270D55-FDAA-4884-8A25-5CA9AD1E14D7 Q27654862-FFC8C2E5-B9DB-4B68-8EAB-86DFD088C34E Q28676262-484A35D9-AB24-448A-A50D-B91CD3F8B471 Q33298405-838F6286-0550-40C6-B67A-F385120547D8 Q33598362-C00DCB6B-DE00-4378-81FA-4BD347BF8D88 Q33598909-762D88A0-87AE-4E97-90B2-793517E35B81 Q33796862-7929EFB0-3B07-4CB5-9606-BDCAB455FBCC Q33861070-BC7F84ED-4DE5-4383-A1A3-C216D56F433E Q33925715-D07A83D5-4E30-4971-B12C-9E564F44C4CC Q33937070-B48B746A-6D54-4C4D-9879-985F7EFA6147 Q34046071-F2CBF238-6EFF-49C7-AD49-C2319D751EF2 Q34144814-C9E6EFF7-8331-4403-AB91-075EFAC27BBB Q34193021-6013B29B-6BEA-4A21-AB8C-AEE7DAD4B5F0 Q34400138-43138E8F-032D-448C-9298-A81D02A07A73 Q34511984-BA608026-3151-44C7-A03F-17CEC22F2FC2 Q34580145-B373B444-04B6-4C11-A840-61C2C9B4447A Q34897103-4B2CAC80-D9F3-4066-BE0E-A57DBB8EB78A Q35098443-FF90FAF2-1D2D-459F-8E20-857142D12283 Q35138521-2B0CA699-0D75-4C41-B785-EA24C3C49321 Q35823366-EE246655-B4A8-4ACE-8BE4-7D6FC4CA4177 Q35850904-BAFD2D96-FCFA-47C3-A0D8-CBACD1E483E8 Q35906102-ED1B1F72-DC53-4DF0-BA8D-AAC3DFE5E4EE Q36008865-C5D9BF3F-D262-46C5-B9F1-BACD7D3F4F52 Q36400800-D86F1D7B-187F-4574-8946-73B370EDC1F9 Q36577160-46DBCD57-F23B-4FD2-9B44-85BCB12FA723 Q36635583-844E989D-A3AE-49F7-A6FD-40080F6083A4 Q36761783-E61EA097-CDD5-4261-9416-085C039AD07F Q36851767-F8C71293-D019-4980-8DBF-8F3DC963EDFB Q36880203-43BE26BE-1E27-4C6D-93C1-A367B567112A Q36976703-08591690-1292-44E4-A13A-0F111A352E8F Q37030603-1A473CFC-F2EC-4278-9C63-E550EF26CD9B Q37067700-48C57E10-8061-4CC2-AA70-D69308461EB7 Q37134291-369E94DE-5D39-4B2B-BE7F-BB451CCD6BBE Q37218553-FEFF758F-0128-428F-94F0-B8CBAEDDDB55 Q37236611-DBF47C04-FB9F-4F36-AA86-21E0AE2521C8 Q37374115-2A6A182B-F956-4B1D-9302-E186DCEC01CD

P2860

Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

http://www.wikidata.org/entity/Q28246156

description

1997 nî lūn-bûn

@nan

1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Amyloid deposition is delayed ...... serum amyloid P component gene

@ast

Amyloid deposition is delayed ...... serum amyloid P component gene

@en

Amyloid deposition is delayed ...... serum amyloid P component gene

@nl

type

label

Amyloid deposition is delayed ...... serum amyloid P component gene

@ast

Amyloid deposition is delayed ...... serum amyloid P component gene

@en

Amyloid deposition is delayed ...... serum amyloid P component gene

@nl

prefLabel

Amyloid deposition is delayed ...... serum amyloid P component gene

@ast

Amyloid deposition is delayed ...... serum amyloid P component gene

@en

Amyloid deposition is delayed ...... serum amyloid P component gene

@nl

P1433

Q28246156-C599FECC-2346-400F-B412-CB29CB0F34BF

P1476

Q28246156-FFF0D856-4546-47E9-8D42-7D3854E5C220

P2093

Q28246156-230A963F-F6EC-4F7F-9B29-2D751E60D536

Q28246156-23BA0B50-1481-4F78-B3D8-5208DE2A92B2

Q28246156-4335C375-04D7-4B23-9EE0-935D625C600F

Q28246156-5223F9C8-FD70-4B88-9A82-904012CE33ED

Q28246156-6797D9D8-2466-475E-9C0E-C01BE6433E7D

Q28246156-6F874D7C-84E7-4593-AFB0-A9E3CBDB45EF

Q28246156-9F707E1D-2A66-407F-B57F-F592F421E579

Q28246156-BE94EDF7-AA4B-4FE3-B877-B401EBB60453

Q28246156-E37EA7D9-B6A0-4C92-A6E5-D33D32320DDC

Q28246156-E962E79F-A534-4788-890D-1B7305E72A8E

P2860

Q28246156-036CE6D9-0042-4901-A6B6-28C015D0C0DA

Q28246156-5D1C8FCF-C7FB-4E72-A618-CF75F1EBE5FE

Q28246156-76E646BD-C977-4A8C-A405-16114E3C5FDC

P2888

Q28246156-BE03A91E-DE3B-4995-BFB2-8D11C8F12D93

P304

Q28246156-7198F4F8-0918-4F55-84EE-3FAD90226EFD

P31

Q28246156-1AABA115-1117-4758-B8A1-AA603B1703B9

P3181

Q28246156-FB5F3548-13BC-4FF6-934B-BB015D540E42

P356

Q28246156-2D10388F-EBCB-415A-9113-93F11C545A82

P407

Q28246156-3736839E-12C9-451D-A68F-9D8DFFB8C7D6

P433

Q28246156-DEF9EDE3-C21A-4CF5-927D-C43146D00A6D

P478

Q28246156-F3E02A6B-F022-4970-8CC8-3A31701D26BC

P577

Q28246156-BC89DA2B-6239-41BF-8EFA-889D6694C19D

P5875

Q28246156-53EF0088-000F-404F-9FD3-73716DB4A7C1

P6179

Q28246156-DE3CC4F0-DC20-47C9-BCB0-ADDA426763BB

P698

Q28246156-1E487C71-0B14-4F57-847C-A42CD8B55F3A

P3181

P356

P1433

Nature Medicine

P1476

Amyloid deposition is delayed ...... serum amyloid P component gene

@en

P2093

A E Bygrave

http://www.w3.org/2001/XMLSchema#string

A McBride

http://www.w3.org/2001/XMLSchema#string

G A Tennent

http://www.w3.org/2001/XMLSchema#string

J Herbert

http://www.w3.org/2001/XMLSchema#string

M B Pepys

http://www.w3.org/2001/XMLSchema#string

M Botto

http://www.w3.org/2001/XMLSchema#string

M C Bickerstaff

http://www.w3.org/2001/XMLSchema#string

M J Walport

http://www.w3.org/2001/XMLSchema#string

P N Hawkins

http://www.w3.org/2001/XMLSchema#string

W L Hutchinson

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis

P2888

P304

855-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

231444

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NM0897-855

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

1997-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13964457

http://www.w3.org/2001/XMLSchema#string

P6179

1005928185

http://www.w3.org/2001/XMLSchema#string

P698

9256275

http://www.w3.org/2001/XMLSchema#string